Skip to content

The mechanism of Danggui Yifei Decoction regulating the efferocytosis of alveolar macrophages to repair chronic lung injury through MerTK/Dnase2a/Myc pathway

The mechanism of Danggui Yifei Decoction regulating the efferocytosis of alveolar macrophages to repair chronic lung injury through MerTK/Dnase2a/Myc pathway

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001307
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-07-08
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe pneumonia

Interventions

Small Airway Function Normal Group:No
Small Airway Dysfunction Group:No

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1)Patients aged 6 to 18 years regardless of gender. (2)Children who meet the diagnostic criteria for pediatric severe pneumonia. (3)Children who meet the traditional Chinese medicine diagnostic criteria for stasis-heat syndrome. (4)Voluntary participation with informed consent obtained from the child and their legal guardian and a signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Presence of other diseases that cause wheezing such as primary ciliary dyskinesia congenital bronchopulmonary dysplasia foreign body aspiration pulmonary tuberculosis cystic fibrosis and children who have undergone umbilical cord blood stem cell transplantation. 2. Presence of severe primary diseases in other systems such as cardiovascular liver kidney and hematopoietic systems or severe malnutrition gastroesophageal reflux primary immunodeficiency psychiatric disorders and other serious diseases that affect their quality of life. 3. Children with potential bleeding risks identified through pre-bronchoalveolar lavage tests of coagulation function and platelet count. 4. Inability to attend regular follow-up visits.

Design outcomes

Primary

MeasureTime frame
Pulmonary Function Test;

Secondary

MeasureTime frame
Efferocytosis index;Analyze the correlation between small airway dysfunction and the efferocytosis function of alveolar macrophages;Gene expression levels of the MerTK/Dnase2a/Myc pathway in the AMf efferocytosis process;

Countries

China

Contacts

Public ContactGuojianning

China-Japan Friendship Hospital

Dr.jane93@outlook.com15319537768

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026